To determine the ability of DCs to stimulate naïve CD4+ T cells into Th17 cells and evaluate the impact of RvE1, we co-cultured naive CD4+ T cells (50,000/200 µl) with CD11c+ DC (1000/200 µl) in U-bottom 96-well plates in 200 μl RPMI containing 10% FBS and 1% Penicillin-Streptomycin. Recent publications show that toll-like receptor (TLR) signaling regulated by DCs was sufficient for T helper cell stimulation and Th17 differentiation (30, 31); Pam3CSK4 is a TLR activator necessary for Th17 polarization (32, 33). Thus, Pam3CSK4 (100 ng) was used to stimulate cells. Six experimental groups were tested: 1) Unstimulated CD4+ T cells 2) CD4+ T cells+ Pam3CSK4 3) DCs+CD4+ T cells 4) DCs+CD4+ T cells+ RvE1 5) DCs+CD4+ T cells+ Pam3CSK4 6) DCs+ CD4+ T cells+ Pam3CSK4+ RvE1. All cells were incubated at 37°C for 5 days. First, cells were treated with 10 nM RvE1 for 24 hours and then stimulated with 100 ng Pam3CSK4. Another dose of RvE1 was applied to the cells on day 3. Cells and supernatants were collected for FACS analysis and Multiplex analysis on day 5.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.